Navigation Links
Matuzumab in Medical News

Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab

Merck Pharmaceuticals from Germany and Takeda Pharmaceuticals from Japan to colloborate in marketing of Merck's cancer drug Matuzumab. Matuzumab is developed by Merck which is in its Phase II // clinical tiral. Takeda Pharmaceuticals will sign agreement with Merck to give royalty and sale be...

Double binding sites on tumor target may provide future combination therapy

...r other types of cancer. An additional drug called matuzumab is in phase II clinical trials. Three years ago...s found again using X-ray crystallography -- that matuzumab binds in a different place from Erbitux. Their bin...has important implications for the clinical use of matuzumab and for developing new therapies that target EGFR....
Matuzumab in Medical Technology

ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting

...fferent anti-EGFR agents, including other monoclonal antibodies, have different biological effects. (#336 Meira et al. Differences in activity between matuzumab and cetuximab in A431 cells may rely on MAPK cascade inhibition.) -- Emerging biomarkers may serve as predictors of clinical response to ERBITUX. (#...
Matuzumab in other areas

Matuzumab - Wikipedia, the free encyclopedia

Matuzumab is a humanized monoclonal antibody for the treatment of cancer. It binds to EGFR with high affinity.

Matuzumab (EMD72000)

... please contact the site administrator at: matuzumab@emdpharmaceuticals.com. Matuzumab is currently under clinical investigation and has not been approved ...

Definition of matuzumab - National Cancer Institute Drug Dictionary

matuzumab. A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, ...

Definition of matuzumab - NCI Dictionary of Cancer Terms

matuzumab. A monoclonal antibody that is being studied in the treatment of ... Matuzumab binds to the epithelial growth factor receptor (EGFR) on tumor cells ...

Matuzumab facts - Freebase

Facts and figures about Matuzumab, taken from Freebase, the world's database. ... If you know more about Matuzumab, you can add more facts here " ...

Merck KGaA 'reconsidering' further development of Matuzumab in ...

FRANKFURT (Thomson Financial) - Merck KGaA said its division Merck Serono's Phase II trial of Matuzumab to treat metastatic colorectal cancer (mCRC) did not meet its ...
Other Tags
(Date:9/2/2014)... 02, 2014 Becker's Healthcare is ... and Chief Information Officer Strategy Roundtables on November ... Becker's Hospital Review Chief Executive Officer and Chief ... health system Chief Executive Officers, Chief Financial Officers, ... system executives through high-quality continuing education, networking ...
(Date:9/2/2014)... BambooIndustry.com, an excellent company in the bamboo industry, has ... floors to celebrate the coming of autumn. To ... frequent callers, BambooIndustry.com launched a promotion for its newly ... floors, BambooIndustry.com provides many kinds of wonderful items for ... floors, click lock floors, wide plank floors and so ...
(Date:9/2/2014)... pm EDT): In a Viewpoint published today in the ... team of Boston researchers call for the implementation of ... United States. The researchers from the Friedman School of ... and Boston Children,s Hospital write that policies taxing nearly ... help people make meaningful dietary changes and substantially reduce ...
(Date:9/2/2014)... 2014 TCG, a leading government technology strategy ... one of the fastest-growing companies in America for the seventh ... was previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, ... grown 86% from 2010 to 2013, ranking the company at ... in America - up 635 spots from 2013! More information ...
(Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... and other new blood thinners is growing at a ... ) continue to mount in courts around the U.S., ... published in American Journal of Medicine, within a year ... to be prescribed Xarelto as warfarin, a blood thinner ...
Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4
(Date:9/2/2014)... present the prestigious Parker/Gentry Award to Mr. Rhett A. ... awareness. The Parker/Gentry Award is given annually by the ... whose efforts have had a significant impact on preserving ... serve as a model to others. , Rhett Butler ... conservation news website that draws more than 2 million ...
(Date:9/2/2014)... the September issue of BioScience , Samantha ... communities in the aftermath of the 2010 Macondo ... hydrocarbon-degrading microbes to the unprecedented deepwater oil plume., ... the responses of indigenous microbial communities to a ... within cells known as ribosomal RNA and analyses ...
(Date:9/2/2014)... American Society of Human Genetics (ASHG) and the ... the National Institutes of Health, have named Elizabeth ... The Wellington School in Columbus, Ohio, the first ... begins today. , The Genetics and Education Fellowship ... their skills, experience, and network to prepare for ...
Breaking Biology News(10 mins):Changing microbial dynamics in the wake of the Macondo blowout 2ASHG and NHGRI award first genetics and education fellowship 2
Other Contents